Cyclopharm Limited - Neraca (Quarterly)

Cyclopharm Limited
AU ˙ ASX
A$ 0.87 ↑0.04 (4.82%)
2025-09-05
BAHAGING PRESYO
Talaan ng Balanse (Quarterly)

Neraca Cyclopharm Limited menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 2 2 32 32 29 29 27 27 20 20 18 18 12 12 28 28 21 21 12 12
Change (%) 0.00 1,588.56 0.00 -7.58 0.00 -9.34 0.00 -23.46 0.00 -10.93 0.00 -35.13 0.00 135.04 0.00 -25.38 0.00 -39.66 0.00
Assets Current 16 16 42 42 43 43 40 40 37 37 37 37 30 30 47 47 42 42 36 36
Change (%) 0.00 164.51 0.00 2.33 0.00 -8.58 0.00 -6.75 0.00 -0.88 0.00 -17.38 0.00 55.96 0.00 -10.00 0.00 -14.44 0.00
Assets 28 28 54 54 56 56 53 53 50 50 49 49 46 46 64 64 62 62 56 56
Change (%) 0.00 92.24 0.00 2.55 0.00 -5.25 0.00 -6.19 0.00 -0.47 0.00 -6.89 0.00 39.59 0.00 -3.07 0.00 -10.00 0.00
Liabilities 11 11 10 10 13 13 12 12 13 13 14 14 14 14 17 17 19 19 20 20
Change (%) 0.00 -10.11 0.00 26.34 0.00 -3.00 0.00 5.80 0.00 10.56 0.00 -5.03 0.00 21.15 0.00 17.25 0.00 2.15 0.00
Equity 17 17 44 44 43 43 41 41 37 37 35 35 32 32 48 48 43 43 36 36
Change (%) 0.00 158.97 0.00 -2.84 0.00 -5.92 0.00 -9.83 0.00 -4.39 0.00 -7.65 0.00 47.40 0.00 -10.14 0.00 -15.52 0.00
Liabilities And Stock Equity 28 28 54 54 56 56 53 53 50 50 49 49 46 46 64 64 62 62 56 56
Change (%) 0.00 92.24 0.00 2.55 0.00 -5.25 0.00 -6.19 0.00 -0.47 0.00 -6.89 0.00 39.59 0.00 -3.07 0.00 -10.00 0.00

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista